Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 26, 2018Annals of OncologyOpen Access

Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

View Full Paper
Ask AI
Bookmark
Share

Authors

DEDennis A. EichenauerUniversity of CologneBABerthe M.P. AlemanCardio-OncologyMAM. André

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Eichenauer et al. (2018) studied this question.

synapsesocial.com/papers/6a704f7eac440176ef28f817https://doi.org/10.1093/annonc/mdy080
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model2001 · 428 citations
  2. 2Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG)2007 · 181 citations
  3. 3Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin’s Lymphoma2016 · 817 citations
  4. 4Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma2017 · 999 citations